Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPartners Grp E Regulatory News (PEY)

Share Price Information for Partners Grp E (PEY)

Share Price is delayed by 15 minutes
Get Live Data
8.06    -0.24 (-2.89%)
Bid:
8.02
Ask:
8.06
Spread: 0.04 (0.499%)
Market Cap: €543.47m
PEY Live PriceLast checked at - London Stock Exchange

Intraday Partners Grp E Share Chart

Additional Directorship

8 May 2008 12:10

Princess Private Equity Holding Ltd08 May 2008 Guernsey, 8 May 2008 Additional Directorship - Listing Rule 9.6.14 The Board of Directors of Princess Private Equity Holding Limited (the"Company") announces that pursuant to Listing Rule 9.6.14, Director Mr. JonathanHooley has been formerly appointed to the board of Close AllBlue Fund Limitedwith effect from 7 May 2008. There have been no other changes to the information set out in Listing Rule9.6.13R (2) to 9.6.13R (6) in respect of Mr Hooley. About Princess: Princess is an investment holding company founded in 1999 and domiciled inGuernsey that invests in private equity and private debt investments. TheCompany is advised in its investment activities by Partners Group AG, a globalalternative asset management firm listed on the SWX Swiss Exchange (tickersymbol: PGHN) with over CHF 24 billion assets under management in privateequity, private debt, private real estate, listed alternative strategies, hedgefunds and alternative beta strategies. Princess aims to provide shareholderswith long-term capital growth and an attractive dividend yield. Princess istraded on the Frankfurt Stock Exchange (ticker symbol: PEY1) and on the LondonStock Exchange (ticker symbol: PEY). Further information:www.princess-privateequity.net Contacts: Princess Private Equity Holding Limited: Ken Ball General Manager Phone: +44 1481 730 946 princess@princess-privateequity.net www.princess-privateequity.net Media enquiries: Partners Group AG Tamara Krebs Communications Tel.: +41 41 768 85 26 tamara.krebs@partnersgroup.net www.partnersgroup.net This document does not constitute an offer to sell or a solicitation of an offerto buy or subscribe for any securities and neither is it intended to be aninvestment advertisement or sales instrument of Princess Private Equity HoldingLimited. The distribution of this document may be restricted by law in certainjurisdictions. Persons into whose possession this document comes must informthemselves about, and observe any such restrictions on the distribution of thisdocument. In particular, this document and the information contained therein isnot for distribution or publication, neither directly nor indirectly, in or intothe United States of America, Canada, Australia or Japan. This document may have been prepared using financial information contained inthe books and records of the product described herein as of the reporting date.This information is believed to be accurate but has not been audited by anythird party. This document may describe past performance, which may not beindicative of future results. The product does not accept any liability foractions taken on the basis of the information provided in this document. Issued and approved by Partners Group (UK) Ltd., authorised and regulated by theFinancial Services Authority in the United Kingdom. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
2nd Aug 20217:00 amRNSTotal Voting Rights
28th Jul 20217:00 amRNSNAV increases by 4.8% in June
27th Jul 20219:00 amRNSDirector Declaration - additional directorship
8th Jul 20214:13 pmRNSDirector/PDMR Shareholding
1st Jul 20217:00 amRNSCompliance with Model Code
1st Jul 20217:00 amRNSTotal Voting Rights
25th Jun 20217:00 amRNSNAV increases by 1.2% in May
18th Jun 20214:37 pmRNSResult of Annual General Meeting
1st Jun 20217:00 amRNSTotal Voting Rights
28th May 20217:00 amRNSNAV increases by 1.5% in April
24th May 20218:19 amRNSPrincess partially realizes its investment in ISP
19th May 20217:00 amRNSPrincess Q1 2021 Results Presentation
4th May 20217:00 amRNSTotal Voting Rights
29th Apr 20217:00 amRNSNAV increases by 7.3% in March
28th Apr 20217:00 amRNSCorrection to the Notes of the Notice of AGM
23rd Apr 20217:00 amRNSNotice of Annual General Meeting
15th Apr 20217:00 amRNSDeclaration of first interim dividend for FY 2021
1st Apr 20217:00 amRNSCompliance with Model Code
1st Apr 20217:00 amRNSTotal Voting Rights
31st Mar 202111:20 amRNSPartners Group to sell GlobalLogic
31st Mar 20217:32 amRNSDiscussions to exit investment in Cerba HealthCare
24th Mar 20217:00 amRNSNAV increases by 0.9% in February
22nd Mar 20217:00 amRNSPrincess publishes Annual Report 2020
1st Mar 20217:00 amRNSTotal Voting Rights
24th Feb 20217:00 amRNSNAV increases by 0.1% in January
16th Feb 20217:00 amRNSQ4 2020 quarterly results presentation
10th Feb 20217:00 amRNSQ4 2020 quarterly results presentation
1st Feb 20217:00 amRNSTotal Voting Rights
28th Jan 20217:00 amRNSNAV increases by 3.1% in December
4th Jan 20217:00 amRNSCompliance with Model Code
4th Jan 20217:00 amRNSTotal Voting Rights
23rd Dec 20207:00 amRNSNAV increases by 3.1% in November
1st Dec 20207:00 amRNSTotal Voting Rights
26th Nov 20207:00 amRNSPrincess publishes October NAV
19th Nov 20202:56 pmRNSDividend Declaration
16th Nov 20207:00 amRNSQ3 2020 quarterly results presentation
4th Nov 20207:00 amRNSQ3 2020 quarterly results presentation
2nd Nov 20207:00 amRNSTotal Voting Rights
27th Oct 20207:00 amRNSNAV increases by 3.8% in September
1st Oct 20207:00 amRNSCompliance with Model Code
1st Oct 20207:00 amRNSTotal Voting Rights
25th Sep 20207:00 amRNSNAV increases by 3.1% in August
1st Sep 20207:00 amRNSTotal Voting Rights
27th Aug 20207:00 amRNSNAV increases by 2.3% in July
25th Aug 20207:00 amRNSPartners Group to sell PCI Pharma Services
17th Aug 20207:00 amRNSPrincess publishes Half-Year Report 2020
7th Aug 20207:00 amRNSPrincess Q2 2020 Results Presentation
3rd Aug 20207:00 amRNSTotal Voting Rights
28th Jul 20207:00 amRNSNew Investment Management Agreement
24th Jul 20207:00 amRNSNAV increases by 2.9% in June

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.